AU2001237525A1 - Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same - Google Patents

Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same

Info

Publication number: AU2001237525A1
Authority: AU; Australia
Prior art keywords: preparation; pharmaceutical compositions; compositions containing; containing same; azetidine derivatives
Prior art date: 2000-03-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2001237525A

Other versions

AU2001237525B2 (en

Inventor

Daniel Achard

Herve Bouchard

Jean Bouquerel

Bruno Filoche

Serge Grisoni

Augustin Hittinger

Michael Myers

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Aventis Pharma SA

Original Assignee

Aventis Pharma SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-03

Filing date

2001-03-01

Publication date

2001-11-22

2000-03-03 Priority claimed from FR0002775A external-priority patent/FR2805818B1/en

2001-03-01 Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA

2001-11-22 Publication of AU2001237525A1 publication Critical patent/AU2001237525A1/en

2005-12-15 Application granted granted Critical

2005-12-15 Publication of AU2001237525B2 publication Critical patent/AU2001237525B2/en

2021-03-01 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

150000001539 azetidines Chemical class 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

AU2001237525A 2000-03-03 2001-03-01 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same Ceased AU2001237525B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR00/02775		2000-03-03
FR0002775A FR2805818B1 (en)	2000-03-03	2000-03-03	AZETIDINE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PCT/FR2001/000600 WO2001064632A1 (en)	2000-03-03	2001-03-01	Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same

Publications (2)

Publication Number	Publication Date
AU2001237525A1 true AU2001237525A1 (en)	2001-11-22
AU2001237525B2 AU2001237525B2 (en)	2005-12-15

Family

ID=8847705

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU3752501A Pending AU3752501A (en)	2000-03-03	2001-03-01	Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
AU2001237525A Ceased AU2001237525B2 (en)	2000-03-03	2001-03-01	Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU3752501A Pending AU3752501A (en)	2000-03-03	2001-03-01	Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same

Country Status (37)

Country	Link
EP (1)	EP1263720B1 (en)
JP (1)	JP2003525268A (en)
KR (1)	KR100786411B1 (en)
CN (1)	CN1185213C (en)
AR (1)	AR027608A1 (en)
AT (1)	ATE432919T1 (en)
AU (2)	AU3752501A (en)
BG (1)	BG107056A (en)
BR (1)	BR0108871A (en)
CA (1)	CA2400116A1 (en)
CY (1)	CY1109343T1 (en)
CZ (1)	CZ20022931A3 (en)
DE (1)	DE60138872D1 (en)
DK (1)	DK1263720T3 (en)
DZ (1)	DZ3313A1 (en)
EA (1)	EA006583B1 (en)
EE (1)	EE05104B1 (en)
ES (1)	ES2328104T3 (en)
FR (1)	FR2805818B1 (en)
HR (1)	HRP20020711A2 (en)
HU (1)	HUP0301404A3 (en)
IL (2)	IL151428A0 (en)
MA (1)	MA26877A1 (en)
ME (1)	MEP24608A (en)
MX (1)	MXPA02008360A (en)
NO (1)	NO324505B1 (en)
NZ (1)	NZ521075A (en)
OA (1)	OA12220A (en)
PL (1)	PL357534A1 (en)
PT (1)	PT1263720E (en)
RS (1)	RS50417B (en)
SI (1)	SI1263720T1 (en)
SK (1)	SK12452002A3 (en)
TW (1)	TWI230153B (en)
UA (1)	UA72593C2 (en)
WO (1)	WO2001064632A1 (en)
ZA (1)	ZA200206905B (en)

Families Citing this family (99)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2002319627A1 (en)	2001-07-20	2003-03-03	Merck And Co., Inc.	Substituted imidazoles as cannabinoid receptor modulators
FR2833842B1 (en) *	2001-12-21	2004-02-13	Aventis Pharma Sa	PHARMACEUTICAL COMPOSITIONS BASED ON AZETIDINE DERIVATIVES
NZ534757A (en)	2002-03-12	2006-07-28	Merck & Co Inc	Substituted amides
US7105526B2 (en)	2002-06-28	2006-09-12	Banyu Pharmaceuticals Co., Ltd.	Benzimidazole derivatives
RU2304580C2 (en)	2002-07-29	2007-08-20	Ф.Хоффманн-Ля Рош Аг	Novel benzodioxols
US7294644B2 (en)	2003-01-02	2007-11-13	Hoffmann-La Roche Inc.	CB 1 receptor inverse agonists
EP1583762B1 (en)	2003-01-02	2008-07-09	F. Hoffmann-La Roche Ag	Pyrrolyl-thiazoles and their use as cb 1 receptor inverse agonists
US7772188B2 (en)	2003-01-28	2010-08-10	Ironwood Pharmaceuticals, Inc.	Methods and compositions for the treatment of gastrointestinal disorders
CA2521606A1 (en) *	2003-04-07	2004-10-21	Cortical Pty Ltd.	Novel methods for the treatment of inflammatory diseases
FR2854633B1 (en)	2003-05-07	2005-06-24	Sanofi Synthelabo	PIPERIDINYL-AND PIPERAZINYL-ALKYLCARBAMATES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
KR20060019587A (en)	2003-06-11	2006-03-03	머크 앤드 캄파니 인코포레이티드	3- 3- Substituted 3-alkyl and 3-alkenyl azetidine derivatives
DE602004012858T2 (en)	2003-06-20	2009-05-14	F. Hoffmann-La Roche Ag	2-AMINOBENZOTHIAZOLE AS CB1 RECEPTOR INVERSE AGONISTS
GB0320983D0 (en) *	2003-09-08	2003-10-08	Biofocus Plc	Compound libraries
WO2005028438A1 (en)	2003-09-22	2005-03-31	Banyu Pharmaceutical Co., Ltd.	Novel piperidine derivative
GB0326221D0 (en) *	2003-11-10	2003-12-17	Merck Sharp & Dohme	Therapeutic agents,compositions,preparations and uses
ATE384058T1 (en)	2003-12-08	2008-02-15	Hoffmann La Roche	THIAZOLE DERIVATIVES
JP4436369B2 (en)	2004-01-28	2010-03-24	エフ．ホフマン−ラロシュアーゲー	Spiro-benzodioxoles and their use as CB1 antagonists
EP1574211A1 (en)	2004-03-09	2005-09-14	Inserm	Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases
EP2305352A1 (en)	2004-04-02	2011-04-06	Merck Sharp & Dohme Corp.	5-alpha-reductase inhibitors for use in the treatment of men with metabolic and anthropometric disorders
CN1950361A (en)	2004-05-10	2007-04-18	霍夫曼-拉罗奇有限公司	Pyrrole or imidazole amides for treating obesity
TW200602314A (en)	2004-05-28	2006-01-16	Tanabe Seiyaku Co	A novel pyrrolidine compound and a process for preparing the same
WO2006045478A1 (en)	2004-10-27	2006-05-04	F. Hoffmann-La Roche Ag	New indole or benzimidazole derivatives
AU2005304039A1 (en)	2004-11-09	2006-05-18	F. Hoffmann-La Roche Ag	Dibenzosuberone derivatives
MX2007012213A (en)	2005-04-06	2007-12-10	Hoffmann La Roche	Pyridine-3-carboxamide derivatives as cb1 inverse agonists.
JP2008179541A (en) *	2005-05-02	2008-08-07	Mochida Pharmaceut Co Ltd	Therapeutic agent for neuropathic pain
ES2574014T3 (en)	2005-05-30	2016-06-14	Msd K.K.	Novel Piperidine Derivative
US7923465B2 (en)	2005-06-02	2011-04-12	Glenmark Pharmaceuticals S.A.	Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
PL1902034T3 (en)	2005-06-02	2011-09-30	Glenmark Pharmaceuticals Sa	Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
EP1916239A4 (en)	2005-08-10	2009-10-21	Banyu Pharma Co Ltd	Pyridone compound
EP1921065B1 (en)	2005-08-24	2010-10-20	Banyu Pharmaceutical Co., Ltd.	Phenylpyridone derivative
WO2007029847A1 (en)	2005-09-07	2007-03-15	Banyu Pharmaceutical Co., Ltd.	Bicyclic aromatic substituted pyridone derivative
EP1940842B1 (en)	2005-09-29	2012-05-30	Merck Sharp & Dohme Corp.	Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
AU2006307046A1 (en)	2005-10-27	2007-05-03	Msd K.K.	Novel benzoxathiin derivative
MY146564A (en)	2005-11-10	2012-08-30	Msd Kk	Aza-substituted spiro derivatives
US7906652B2 (en) *	2005-11-28	2011-03-15	Merck Sharp & Dohme Corp.	Heterocycle-substituted 3-alkyl azetidine derivatives
AR058199A1 (en) *	2005-11-28	2008-01-23	Merck & Co Inc	DERIVATIVES OF 3- RENTED ALQUILAZETIDINA WITH HETEROCICLOS
US7629346B2 (en)	2006-06-19	2009-12-08	Hoffmann-La Roche Inc.	Pyrazinecarboxamide derivatives as CB1 antagonists
AU2007283113A1 (en)	2006-08-08	2008-02-14	Sanofi-Aventis	Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use
US7781593B2 (en)	2006-09-14	2010-08-24	Hoffmann-La Roche Inc.	5-phenyl-nicotinamide derivatives
EP2698157B1 (en)	2006-09-22	2015-05-20	Merck Sharp & Dohme Corp.	Method of treatment using fatty acid synthesis inhibitors
WO2008038692A1 (en)	2006-09-28	2008-04-03	Banyu Pharmaceutical Co., Ltd.	Diaryl ketimine derivative
AU2008233662B2 (en)	2007-04-02	2012-08-23	Msd K.K.	Indoledione derivative
US8969514B2 (en)	2007-06-04	2015-03-03	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US7879802B2 (en)	2007-06-04	2011-02-01	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2025674A1 (en)	2007-08-15	2009-02-18	sanofi-aventis	Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs
US8304434B2 (en) *	2007-10-04	2012-11-06	Merck Sharp & Dohme Corp.	Substituted aryl sulfone derivatives as calcium channel blockers
CA2714617A1 (en)	2008-03-06	2009-09-11	Banyu Pharmaceutical Co., Ltd.	Alkylaminopyridine derivative
US20110015198A1 (en)	2008-03-28	2011-01-20	Banyu Pharmaceutical Co., Inc.	Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism
EP3239170B1 (en)	2008-06-04	2019-03-20	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2301936A1 (en)	2008-06-19	2011-03-30	Banyu Pharmaceutical Co., Ltd.	Spirodiamine-diarylketoxime derivative
UY31968A (en)	2008-07-09	2010-01-29	Sanofi Aventis	NEW HETEROCYCLIC DERIVATIVES, THEIR PROCESSES FOR THEIR PREPARATION, AND THEIR THERAPEUTIC USES
EP3241839B1 (en)	2008-07-16	2019-09-04	Bausch Health Ireland Limited	Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
EP2319841A1 (en)	2008-07-30	2011-05-11	Msd K.K.	(5-membered)-(5-membered) or (5-membered)-(6-membered) fused ring cycloalkylamine derivative
CA2741125A1 (en)	2008-10-22	2010-04-29	Merck Sharp & Dohme Corp.	Novel cyclic benzimidazole derivatives useful anti-diabetic agents
CA2741644C (en)	2008-10-30	2013-05-07	Merck Sharp & Dohme Corp.	Isonicotinamide orexin receptor antagonists
WO2010051206A1 (en)	2008-10-31	2010-05-06	Merck Sharp & Dohme Corp.	Novel cyclic benzimidazole derivatives useful anti-diabetic agents
CA2743489A1 (en)	2008-11-17	2010-05-20	Merck Sharp & Dohme Corp.	Substituted bicyclic amines for the treatment of diabetes
WO2011011506A1 (en)	2009-07-23	2011-01-27	Schering Corporation	Spirocyclic oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
US20120220567A1 (en)	2009-07-23	2012-08-30	Shipps Jr Gerald W	Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
CA2771278A1 (en)	2009-08-26	2011-03-03	Sanofi	Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
US8895596B2 (en)	2010-02-25	2014-11-25	Merck Sharp & Dohme Corp	Cyclic benzimidazole derivatives useful as anti-diabetic agents
EP2563764B1 (en)	2010-04-26	2015-02-25	Merck Sharp & Dohme Corp.	Novel spiropiperidine prolylcarboxypeptidase inhibitors
WO2011143057A1 (en)	2010-05-11	2011-11-17	Merck Sharp & Dohme Corp.	Novel prolylcarboxypeptidase inhibitors
WO2011156246A1 (en)	2010-06-11	2011-12-15	Merck Sharp & Dohme Corp.	Novel prolylcarboxypeptidase inhibitors
US9616097B2 (en)	2010-09-15	2017-04-11	Synergy Pharmaceuticals, Inc.	Formulations of guanylate cyclase C agonists and methods of use
US8669254B2 (en)	2010-12-15	2014-03-11	Hoffman-La Roche Inc.	Pyridine, pyridazine, pyrimidine or pyrazine carboxamides as HDL-cholesterol raising agents
EP2677869B1 (en)	2011-02-25	2017-11-08	Merck Sharp & Dohme Corp.	Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
WO2012120053A1 (en)	2011-03-08	2012-09-13	Sanofi	Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8871758B2 (en)	2011-03-08	2014-10-28	Sanofi	Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
US8828994B2 (en)	2011-03-08	2014-09-09	Sanofi	Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8809325B2 (en)	2011-03-08	2014-08-19	Sanofi	Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof
EP2683699B1 (en)	2011-03-08	2015-06-24	Sanofi	Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120058A1 (en)	2011-03-08	2012-09-13	Sanofi	Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
WO2012120057A1 (en)	2011-03-08	2012-09-13	Sanofi	Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
WO2012120052A1 (en)	2011-03-08	2012-09-13	Sanofi	Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
US8809324B2 (en)	2011-03-08	2014-08-19	Sanofi	Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
AR088352A1 (en)	2011-10-19	2014-05-28	Merck Sharp & Dohme	ANTAGONISTS OF THE RECEIVER OF 2-PIRIDILOXI-4-NITRILE OREXINE
AU2013296470B2 (en)	2012-08-02	2016-03-17	Merck Sharp & Dohme Corp.	Antidiabetic tricyclic compounds
WO2014028669A1 (en) *	2012-08-15	2014-02-20	Biogen Idec Ma Inc.	Novel compounds for modulation of ror-gamma activity
AU2014219020A1 (en)	2013-02-22	2015-07-23	Merck Sharp & Dohme Corp.	Antidiabetic bicyclic compounds
WO2014139388A1 (en)	2013-03-14	2014-09-18	Merck Sharp & Dohme Corp.	Novel indole derivatives useful as anti-diabetic agents
US9708367B2 (en)	2013-03-15	2017-07-18	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase and their uses
CA2905435A1 (en)	2013-03-15	2014-09-25	Synergy Pharmaceuticals Inc.	Compositions useful for the treatment of gastrointestinal disorders
JP6606491B2 (en)	2013-06-05	2019-11-13	シナジーファーマシューティカルズインコーポレイテッド	Ultra high purity agonist of guanylate cyclase C, method for producing and using the same
WO2015051496A1 (en)	2013-10-08	2015-04-16	Merck Sharp & Dohme Corp.	Antidiabetic tricyclic compounds
FR3017867A1 (en) *	2014-02-21	2015-08-28	Inventiva	NOVEL PHENYLAZETIDINE CARBOXYLATE OR CARBOXAMIDE COMPOUNDS
JP6769963B2 (en)	2014-08-29	2020-10-14	ティエエッセファルマソチエタレスポンサビリタリミタータ	Inhibitor of α-amino-β-carboxymuconic acid semialdehyde decarboxylase
RU2716814C2 (en) *	2015-05-20	2020-03-17	Интегрейтив Рисерч Лабораторис Свиден АБ	Novel azetidine derivatives, useful as modulators of cortical catecholaminergic neurotransmission
CN108137569B (en) *	2015-10-23	2022-03-15	埃斯蒂文制药股份有限公司	Substituted morpholine derivatives having anti-pain activity
AU2017342083A1 (en)	2016-10-14	2019-04-11	Tes Pharma S.R.L.	Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
EP3551176A4 (en)	2016-12-06	2020-06-24	Merck Sharp & Dohme Corp.	Antidiabetic heterocyclic compounds
BR112020000086A2 (en) *	2017-07-03	2020-07-07	Glaxosmithkline Intellectual Property Development Limited	2- (4-chlorophenoxy) -n - ((1- (2- (4-chlorophenoxy) ethinazetidin-3-yl) methyl) acetamide derivatives and related compounds as inhibitors of atf4 for the treatment of cancer and other diseases
KR102646322B1 (en)	2018-04-17	2024-03-11	톈진 헤메이 파마슈티칼 컴퍼니 리미티드	Isoindole derivatives
CN108794389B (en) *	2018-08-20	2021-03-23	利尔化学股份有限公司	Preparation method of 2,3,5, 6-tetrachloro-4-methylsulfonylpyridine
KR20210111248A (en)	2018-11-20	2021-09-10	테스 파마 에스.알.엘.	Inhibitors of α-amino-β-carboxymuconic acid semialdehyde decarboxylase
WO2020167706A1 (en)	2019-02-13	2020-08-20	Merck Sharp & Dohme Corp.	5-alkyl pyrrolidine orexin receptor agonists
CN110551133A (en) *	2019-07-23	2019-12-10	上海合全药业股份有限公司	Process for preparing tert-butyl-5- (hydroxymethyl) -7-oxa-2-azaspiro [3.5] nonane-2-carboxylic acid ester
WO2021026047A1 (en)	2019-08-08	2021-02-11	Merck Sharp & Dohme Corp.	Heteroaryl pyrrolidine and piperidine orexin receptor agonists
CR20230089A (en)	2020-08-18	2023-04-11	Merck Sharp & Dohme Llc	Bicycloheptane pyrrolidine orexin receptor agonists

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4242261A (en) *	1979-07-19	1980-12-30	A. H. Robins Company, Inc.	Production of methylene-cycloamines
FR2649100B1 (en) *	1989-06-29	1994-03-04	Laboratorios Dr Esteve Sa	NOVEL AZETIDINES, THEIR PREPARATION AND THEIR APPLICATION AS INTERMEDIATES FOR THE PREPARATION OF COMPOUNDS WITH ANTIMICROBIAL ACTIVITY
US5198449A (en) *	1990-04-27	1993-03-30	A. H. Robins Company Incorporated	N-substituted alpha-arylazacycloalkylmethanamines and their use as cardiovascular agents
GB2285977B (en) *	1994-01-24	1998-05-27	Du Pont Merck Pharma	Novel azetidine antipsychotic drugs
EP0842172A1 (en) *	1995-06-29	1998-05-20	Novo Nordisk A/S	Novel substituted azacyclic or azabicyclic compounds
HN1998000118A (en) *	1997-08-27	1999-02-09	Pfizer Prod Inc	2 - AMINOPYRIDINES CONTAINING SUBSTITUTES FOR CONDENSED RINGS.
GB9719187D0 (en) *	1997-09-09	1997-11-12	Glaxo Group Ltd	Compounds
GB9815880D0 (en) *	1998-07-21	1998-09-16	Pfizer Ltd	Heterocycles

2000
- 2000-03-03 FR FR0002775A patent/FR2805818B1/en not_active Expired - Fee Related
2001
- 2001-01-03 UA UA2002097699A patent/UA72593C2/en unknown
- 2001-02-23 TW TW090104206A patent/TWI230153B/en not_active IP Right Cessation
- 2001-03-01 PL PL01357534A patent/PL357534A1/en not_active Application Discontinuation
- 2001-03-01 RS YUP-658/02A patent/RS50417B/en unknown
- 2001-03-01 BR BR0108871-8A patent/BR0108871A/en not_active Application Discontinuation
- 2001-03-01 MX MXPA02008360A patent/MXPA02008360A/en active IP Right Grant
- 2001-03-01 IL IL15142801A patent/IL151428A0/en unknown
- 2001-03-01 SK SK1245-2002A patent/SK12452002A3/en unknown
- 2001-03-01 AT AT01909937T patent/ATE432919T1/en active
- 2001-03-01 EP EP01909937A patent/EP1263720B1/en not_active Expired - Lifetime
- 2001-03-01 DZ DZ013313A patent/DZ3313A1/en active
- 2001-03-01 PT PT01909937T patent/PT1263720E/en unknown
- 2001-03-01 HU HU0301404A patent/HUP0301404A3/en unknown
- 2001-03-01 OA OA1200200268A patent/OA12220A/en unknown
- 2001-03-01 DK DK01909937T patent/DK1263720T3/en active
- 2001-03-01 EA EA200200940A patent/EA006583B1/en not_active IP Right Cessation
- 2001-03-01 JP JP2001563475A patent/JP2003525268A/en active Pending
- 2001-03-01 DE DE60138872T patent/DE60138872D1/en not_active Expired - Lifetime
- 2001-03-01 KR KR1020027011515A patent/KR100786411B1/en not_active IP Right Cessation
- 2001-03-01 CZ CZ20022931A patent/CZ20022931A3/en unknown
- 2001-03-01 ME MEP-246/08A patent/MEP24608A/en unknown
- 2001-03-01 NZ NZ521075A patent/NZ521075A/en unknown
- 2001-03-01 SI SI200130936T patent/SI1263720T1/en unknown
- 2001-03-01 AU AU3752501A patent/AU3752501A/en active Pending
- 2001-03-01 CN CNB018081819A patent/CN1185213C/en not_active Expired - Fee Related
- 2001-03-01 ES ES01909937T patent/ES2328104T3/en not_active Expired - Lifetime
- 2001-03-01 AU AU2001237525A patent/AU2001237525B2/en not_active Ceased
- 2001-03-01 EE EEP200200487A patent/EE05104B1/en not_active IP Right Cessation
- 2001-03-01 WO PCT/FR2001/000600 patent/WO2001064632A1/en active IP Right Grant
- 2001-03-01 CA CA002400116A patent/CA2400116A1/en not_active Abandoned
- 2001-03-02 AR ARP010101023A patent/AR027608A1/en active IP Right Grant
2002
- 2002-08-16 MA MA26781A patent/MA26877A1/en unknown
- 2002-08-22 IL IL151428A patent/IL151428A/en not_active IP Right Cessation
- 2002-08-28 ZA ZA200206905A patent/ZA200206905B/en unknown
- 2002-08-30 HR HR20020711A patent/HRP20020711A2/en not_active Application Discontinuation
- 2002-09-02 NO NO20024175A patent/NO324505B1/en not_active IP Right Cessation
- 2002-09-03 BG BG107056A patent/BG107056A/en unknown
2009
- 2009-09-02 CY CY20091100924T patent/CY1109343T1/en unknown

Publication	Publication Date	Title
AU2001237525A1 (en)	2001-11-22	Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
DZ3313A1 (en)	2001-09-07	Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
AU2001237526A1 (en)	2001-11-22	Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
HUP0400636A3 (en)	2004-09-28	Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
DZ3311A1 (en)	2001-09-07	Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
HUP0103341A3 (en)	2002-10-28	Azetidine derivatives, preparation and pharmaceutical compositions thereof
AU781269C (en)	2006-11-30	Pharmaceutical compositions
AU2001290257A1 (en)	2002-06-27	Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A2 (en)	2003-05-01	Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001250420A1 (en)	2001-10-23	Pharmaceutical compositions
AU2001274307A1 (en)	2002-01-02	Pharmaceutical compositions
AU2001235737A1 (en)	2001-09-12	Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same
AU2001290239A1 (en)	2002-04-02	Medicinal composition
AU2001292331A1 (en)	2002-06-27	5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
AU2001292331A2 (en)	2003-07-24	5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
AU2001273919A1 (en)	2001-10-23	Pharmaceutical compositions
IL159219A0 (en)	2004-06-01	Pyrrolidine oxadiazole derivatives, their preparation and pharmaceutical compositions containing them
AU3560601A (en)	2001-08-07	Novel isoquinoline derivatives, preparation method and pharmaceutical compositions containing them
AU2002360117A1 (en)	2003-07-03	Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
HUP0300330A3 (en)	2003-09-29	Oligosaccharides, pharmaceutical compositions containing them and preparation thereof
AU4085201A (en)	2001-09-24	Pharmaceutical composition
IL154986A0 (en)	2003-10-31	Triazolo-epothilone derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
AU2001274171A1 (en)	2001-12-11	Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof
AU4884701A (en)	2001-11-20	Malonanilic acid derivatives, medicinal compositions containing the same and usethereof
AU2001250625A1 (en)	2001-10-30	19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them